InvestorsHub Logo
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

Re: None

Wednesday, 09/27/2017 7:58:12 AM

Wednesday, September 27, 2017 7:58:12 AM

Post# of 1434
Aradigm (ARDM) PT Raised to $10 at Ladenburg Thalmann

Ladenburg Thalmann analyst Matthew Kaplan raised his price target on Aradigm (NASDAQ: ARDM) to $10.00 (from $7.50) while maintaining a Buy rating as FDA accepts Linhaliq NDA with priority review.

The analyst notes the PDUDA date is 1/26/18.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.